Osaic Holdings
ICCM icon

Osaic Holdings’s IceCure Medical ICCM Stock Holding History

Osaic Holdings’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-508
Closed -$18.3K – 7506
2024
Q1 		$18.3K Buy
508
+266
+110% +$10.4K ﹤0.01% 5418
2023
Q4 		$7.76K Buy
+242
New +$6.41K ﹤0.01% 5960
2023
Q3 		– Sell
-189
Closed -$6.58K – 7452
2023
Q2 		$6.58K Hold
189
– – ﹤0.01% 6187
2023
Q1 		$6.52K Buy
189
+17
+10% +$632 ﹤0.01% 6212
2022
Q4 		$8K Hold
172
– – ﹤0.01% 6061
2022
Q3 		$7K Buy
172
+83
+93% +$4.1K ﹤0.01% 6192
2022
Q2 		$4K Buy
89
+22
+33% +$1.32K ﹤0.01% 6597
2022
Q1 		$5K Buy
67
+11
+20% +$853 ﹤0.01% 6477
2021
Q4 		$5K Sell
56
-52
-48% -$8.69K ﹤0.01% 6626
2021
Q3 		$29K Buy
+108
New +$32K ﹤0.01% 5508

Other funds holding ICCM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings's ICCM Position: Q2 2024 in Review

Osaic Holdings sold out of IceCure Medical (ICCM) in Q2 2024, closing a stake of 508 shares — an estimated $18.3K sold.

Osaic Holdings first reported a position in ICCM in Q3 2021 and held it in 10 quarters. The position peaked at $29K in Q3 2021. 14 funds tracked by Wall St. Rank hold ICCM as of Q2 2024.

  • Osaic Holdings reported no remaining IceCure Medical position as of Q2 2024 after selling out during the quarter.
  • Osaic Holdings sold 508 IceCure Medical shares in Q2 2024, an estimated $18.3K.
  • Osaic Holdings first reported a position in IceCure Medical in Q3 2021 and held it in 10 quarters.
  • Osaic Holdings's IceCure Medical position peaked at $29K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2024.

Based on Osaic Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.